Quantitative Polypharmacology Profiling Based on a Multifingerprint Similarity Predictive Approach

We present a new quantitative ligand-based bioactivity prediction approach employing a multifingerprint similarity search algorithm, enabling the polypharmacological profiling of small molecules. Quantitative bioactivity predictions are made on the basis of the statistical distributions of multiple Tanimoto similarity θ values, calculated through 13 different molecular fingerprints, and of the variation of the measured biological activity, reported as ΔpIC50, for all of the ligands sharing a given protein drug target. The application data set comprises as much as 4241 protein drug targets as well as 418 485 ligands selected from ChEMBL (release 25) by employing a set of well-defined filtering rules. Several large internal and external validation studies were carried out to demonstrate the robustness and the predictive potential of the herein proposed method. Additional comparative studies, carried out on two freely available and well-known ligand-target prediction platforms, demonstrated the reliability of our proposed approach for accurate ligand-target matching. Moreover, two applicative cases were also discussed to practically describe how to use our predictive algorithm, which is freely available as a user-friendly web platform. The user can screen single or multiple queries at a time and retrieve the output as a terse html table or as a json file including all of the information concerning the explored similarities to obtain a deeper understanding of the results. High-throughput virtual reverse screening campaigns, allowing for a given query compound the quick detection of the potential drug target from a large collection of them, can be carried out in batch on demand.

[1]  Chee-Keong Kwoh,et al.  Computational prediction of drug-target interactions using chemogenomic approaches: an empirical survey , 2019, Briefings Bioinform..

[2]  R. Sánchez-Prieto,et al.  p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story , 2016, Front. Cell Dev. Biol..

[3]  D. Alberga,et al.  Accelerating Drug Discovery by Early Protein Drug Target Prediction Based on a Multi-Fingerprint Similarity Search † , 2019, Molecules.

[4]  George Papadatos,et al.  The ChEMBL database in 2017 , 2016, Nucleic Acids Res..

[5]  F. Zetterberg,et al.  State of affairs: Design and structure-activity relationships of reversible P2Y12 receptor antagonists. , 2016, Bioorganic & medicinal chemistry letters.

[6]  Shuxing Zhang,et al.  Polypharmacology: drug discovery for the future , 2013, Expert review of clinical pharmacology.

[7]  Daniela Trisciuzzi,et al.  A New Approach for Drug Target and Bioactivity Prediction: The Multifingerprint Similarity Search Algorithm (MuSSeL) , 2018, J. Chem. Inf. Model..

[8]  Jean-Louis Reymond,et al.  The polypharmacology browser: a web-based multi-fingerprint target prediction tool using ChEMBL bioactivity data , 2017, Journal of Cheminformatics.

[9]  K. Peter,et al.  Current and future antiplatelet therapies: emphasis on preserving haemostasis , 2018, Nature Reviews Cardiology.

[10]  Olivier Michielin,et al.  SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules , 2019, Nucleic Acids Res..

[11]  Olivier Michielin,et al.  Shaping the interaction landscape of bioactive molecules , 2013, Bioinform..

[12]  Maykel Cruz-Monteagudo,et al.  Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde? , 2014, Drug discovery today.

[13]  Alberga Domenico,et al.  De Novo Drug Design of Targeted Chemical Libraries Based on Artificial Intelligence and Pair-Based Multiobjective Optimization. , 2020 .

[14]  H. Zachrisson,et al.  Lead optimization of ethyl 6-aminonicotinate acyl sulfonamides as antagonists of the P2Y12 receptor. separation of the antithrombotic effect and bleeding for candidate drug AZD1283. , 2013, Journal of medicinal chemistry.

[15]  Jean-Louis Reymond,et al.  Polypharmacology Browser PPB2: Target Prediction Combining Nearest Neighbors with Machine Learning , 2018, J. Chem. Inf. Model..

[16]  Yushe Yang,et al.  Optimization of P2Y12 Antagonist Ethyl 6-(4-((Benzylsulfonyl)carbamoyl)piperidin-1-yl)-5-cyano-2-methylnicotinate (AZD1283) Led to the Discovery of an Oral Antiplatelet Agent with Improved Druglike Properties. , 2019, Journal of medicinal chemistry.

[17]  G. Rastelli,et al.  LigAdvisor: a versatile and user-friendly web-platform for drug design , 2021, Nucleic Acids Res..

[18]  S. Knapp,et al.  Bioisosteric Replacement of Arylamide-linked Spine Residues by N-Acylhydrazones and Selenophenes as Design Strategy to Novel Dibenzosuberone Derivatives as Type I½ p38 MAP Kinase Inhibitors. , 2020, Journal of medicinal chemistry.

[19]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[20]  S. Koul,et al.  Role of p38 MAP Kinase Signal Transduction in Solid Tumors. , 2013, Genes & cancer.

[21]  Andreas Bender,et al.  In Silico Target Predictions: Defining a Benchmarking Data Set and Comparison of Performance of the Multiclass Naïve Bayes and Parzen-Rosenblatt Window , 2013, J. Chem. Inf. Model..

[22]  Ya Chen,et al.  Validation strategies for target prediction methods , 2019, Briefings Bioinform..

[23]  Antonio Lavecchia,et al.  In silico methods to address polypharmacology: current status, applications and future perspectives. , 2016, Drug discovery today.

[24]  Dong-Sheng Cao,et al.  Current advances in ligand‐based target prediction , 2020, WIREs Computational Molecular Science.

[25]  J. Bajorath,et al.  Polypharmacology: challenges and opportunities in drug discovery. , 2014, Journal of medicinal chemistry.

[26]  T. Tuccinardi,et al.  Recent Advances in In Silico Target Fishing , 2021, Molecules.